Posted inMedical Technology Endoscopic procedure can help slow weight rebound from stopping GLP-1 treatment: study April 26, 2026 A simple outpatient procedure currently used for type 2 diabetes patients in Europe can help those on Eli Lilly’s obesity…
Posted inMedical Technology Thermo Fisher sees higher Q1 earnings amid strong biopharma demand April 25, 2026 Thermo Fisher Scientific reported “a strong start to the year,” buoyed by strong demand from its pharma and biotech customers,…
Posted inMedical Technology McKesson swaps minority stake in surgical unit to Apollo Funds for $1.25B April 22, 2026 McKesson let go of a minority share of its medical/surgical solutions division for $1.25 billion to Apollo Funds as part…
Posted inMedical Technology AcuityMD raises $80M to help bolster AI in the medtech industry April 22, 2026 AcuityMD has raised $80 million—with a company valuation now nearing $1 billion—to use its artificial intelligence (AI) platform to boost…
Posted inMedical Technology Pulnovo Medical scores $100M in finance round led by Medtronic April 21, 2026 Pulnovo Medical, a Chinese medtech focused on therapies that target pulmonary hypertension and heart failure, hauled in $100 million in…
Posted inMedical Technology Foundation Medicine expands Bristol Myers Squibb collaboration with new diagnostic target April 21, 2026 Roche’s Foundation Medicine is deepening its longstanding ties with Bristol Myers Squibb as the companies team up on a new…
Posted inMedical Technology Johnson & Johnson teams up with Viz.ai on hematoma detection April 21, 2026 Johnson & Johnson is working with the artificial intelligence (AI)-based disease detection and care coordination platform Viz.ai to boost its…
Posted inMedical Technology Roche boosts diagnostics offerings with $595M Saga buyout April 20, 2026 Roche is handing over $595 million to bolster its Foundation Medicine business with a deal to snap up SAGA Diagnostics.…
Posted inMedical Technology Abbott lowers EPS guidance on Exact Sciences buy as shares slide April 17, 2026 Abbott is dealing with integrating a big new buyout into its business alongside a weaker-than-expected respiratory disease season—plus ongoing issues…
Posted inMedical Technology Qiagen launches latest diagnostic for bloodstream infections April 16, 2026 Qiagen is moving into syndromic testing for bloodstream infections with the launch of the Netherlands-based diagnostics maker's newest offering. Dubbed…